ArticleBMC cancer2023

CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.

Yihua Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.